COMMUNIQUÉS West-GlobeNewswire

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
03/04/2025
VALENCIA, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the U.S. commercial [...]
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03/04/2025
CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]
I-Mab Reports Full Year 2024 Financial Results and Provides Business Update
03/04/2025
Continued positive momentum in givastomig Phase 1b combination trial in first-line gastric cancer, with topline dose escalation data (n=17) expected in 2H 2025 Enrollment completed ahead of schedule in the first [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2025
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Sanofi: Information concerning the total number of voting rights and shares - February 2025
03/04/2025
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - FEVRIER 2025
03/04/2025
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Best SARMs For Cutting, Bulking & Muscle Growth 2025: Top Fat Loss Sarms Stack For Sale On The Market - CrazyBulk
03/04/2025
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Welcome to the world of SARMs, the selective androgen receptor modulators that have gained popularity in the fitness and bodybuilding community. SARMs offer a unique approach [...]
HealthRecon Connect Achieves ISO 22301:2019 Certification for Business Continuity Management
03/04/2025
DALLAS, April 03, 2025 (GLOBE NEWSWIRE) -- HealthRecon Connect is proud to announce that it has been awarded the ISO 22301:2019 certification, an internationally recognized standard for Business Continuity Management [...]
OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025
03/04/2025
OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025 OSE-CYTOMASK®, a new CIS-Demasking 1 cytokine bispecific technology. CLEC-1, a novel immune checkpoint target. NANTES, [...]
OSE Immunotherapeutics présente ses dernières avancées précliniques en Immuno-Oncologie - Au congrès annuel 2025 de l’AACR
03/04/2025
OSE Immunotherapeutics présente ses dernières avancées précliniques en Immuno-Oncologie Au congrès annuel 2025 de l’AACR OSE-CYTOMASK®, une nouvelle technologie bispécifique de CIS-Démasquage 1 des cytokines. CLEC-1, [...]
SAFE - REPORT DE LA PUBLICATION DES RESULTATS ANNUELS ET DU RAPPORT FINANCIER ANNUEL 2024
03/04/2025
REPORT DE LA PUBLICATION DES RESULTATS ANNUELS ET DU RAPPORT FINANCIER ANNUEL 2024 Fleurieux-sur-l’Arbresle - France - le 3 avril 2025 à 18h . Safe Group annonce le report de la publication des résultats 2024 et du [...]
EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples
03/04/2025
EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples Paris, France (3 April 2025) – EssilorLuxottica and Roger Federer announce today the renewal of [...]
EssilorLuxottica et Roger Federer étendent la collaboration mondiale exclusive entre la marque RF et Oliver Peoples pour des collections de lunettes
03/04/2025
EssilorLuxottica et Roger Federer étendent la collaboration mondiale exclusive entre la marque RF et Oliver Peoples pour des collections de lunettes Paris, France (3 avril 2025) – EssilorLuxottica et Roger Federer [...]
Valneva SE Shareholding Declaration - March 2025
03/04/2025
VALNEVA Declaration of shares and voting rights March 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]
Déclaration d'actions et de droits de vote de la société Valneva SE - Mars 2025
03/04/2025
VALNEVA Déclaration d’actions et de droits de vote 31 mars 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 rue [...]
Resolutions from the Annual General Meeting 2025
03/04/2025
Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2024 Approval of distribution of profit with payment of an [...]
Arialief Vitamins Reviews & Complaints (EXPOSED 2025) Arialief For Neuropathy and Nerve Health
03/04/2025
Why is Arialief more advantageous in today's era? FINDLAY, Ohio, April 03, 2025 (GLOBE NEWSWIRE) -- Arialief Vitamins is a pure product mainly designed to aid sciatic nerve health. The supplement is prepared with [...]
Odosek Lab Solutions Expands Mobile DNA Testing Services in Columbia, South Carolina
03/04/2025
Columbia, SC, April 03, 2025 (GLOBE NEWSWIRE) -- Odosek Lab Solutions announced today the expansion of its mobile DNA and drug testing services throughout Columbia, South Carolina and surrounding areas. The company's [...]
H.H.C. Group Releases White Paper on High-Cost Healthcare Claims and Cost-Containment Strategies
03/04/2025
ROCKVILLE, Md., April 03, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), the leader in reducing healthcare costs by providing high-quality cost containment using claim negotiation, repricing and independent review [...]

Pages